Profund Advisors’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-6,434
Closed -$299K 1100
2023
Q2
$299K Buy
+6,434
New +$222K 0.02% 724

Profund Advisors's DICE Position: Q3 2023 in Review

Profund Advisors sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 6,434 shares — an estimated $299K sold.

Profund Advisors first reported a position in DICE in Q2 2023 and held it in 1 quarter. The position peaked at $299K in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

  • Profund Advisors reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Profund Advisors sold 6,434 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $299K.
  • Profund Advisors first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • Profund Advisors's DICE Therapeutics, Inc. Common Stock position peaked at $299K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Profund Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.